Whole-exome sequencing in gynecologic mucosal melanomas (MMs), including the rare ovarian ones, often identifies mutations in NRAS, NF1, KMT2D, MUC16, and KIT. Nevertheless, they present a lower frequency of canonical BRAF mutations, making them less sensitive to BRAF/MEK inhibitors. This evidence concerns the gene NRAS and mucosal melanoma.